Laboratories provide essential support functions in biopharmaceutical development: from cell-line development through process validation, environmental monitoring, and preclinical analyses . . . to product characterization, formulation, and stability testing. Regulatory compliance is important across the gamut of such laboratory work. Modern companies are implementing lean concepts that facilitate organization and workflows in laboratory operations. And companies around the world can use the latest technology to ensure data integrity for their analytical results. Included herein are two articles that originally appeared…
Tuesday, October 18, 2022 Daily Archives
Lilly $487m+ Akouos buy to add hearing loss gene therapy programs
Nearly two years after buying Prevail Therapeutics, Eli Lilly is doubling down on its gene therapy presence through the acquisition of Akouos. Eli Lilly will pay $12.50 a share for Boston, Massachusetts-based Akouos, equating to around $487 million. The Big Pharma firm could pay a further one contingent value right (CVR) of up to $3 per share, adding another $123 million to the deal. Akouos is developing gene therapies to address hearing loss conditions, with its lead candidate AK-OTOF set…
A supply chain existential crisis? Cell therapy firms must move from paper
There is an existential crisis in the cell therapy space as firms face limited and outdated options to track personalized medicines, says supply chain technology developer ATMPS. ATMPS’ software, Hataali, uses blockchain technology to track cell therapy products from the initial harvesting of cells from a clinical trial participant to the production facility and back through a series of nodes. The software received a US patent for the use of blockchain in personalized medicine earlier this year, and hopes to…